title: Atomoxetine-induced mydriasis in a child patient.
authors.affiliation: Department of Child and Adolescent Psychiatry, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, 34147, Turkey, mkbahali@yahoo.com.
authors.forename: Kayhan
authors.initials: K
authors.lastname: Bahali
authors.forename: Hamiyet
authors.initials: H
authors.lastname: Ipek
authors.forename: Ozhan
authors.initials: O
authors.lastname: Yalcin
authors.forename: Ozgur
authors.initials: O
authors.lastname: Orum
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D016907:Adverse Drug Reaction Reporting Systems; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D015878:Mydriasis / Q000139:chemically induced*; D011437:Propylamines / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride